Table 2 EC50 values derived from the in vitro data on the neurotoxicity of MGO in human neuronal cell models reported in the literature

From: Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans

Human neuronal cell models

EC50a, (μM)

Exposure time, (h)

Endpoints

References

SH-SY5Y

710.0

24

Mitochondrial function (MTT assay)

20

SK-N-MC

372.9

48

Mitochondrial function (WST assay)

22

SK-N-SH

1179.0

24

Mitochondrial function (Resazurin assay)

21

M17

809.2

Unspecified

Viability assessment (method unspecified)

73

Human induced pluripotent stem cell (iPSC)-derived neurons

>1000

Unspecified

Viability assessment (method unspecified)

73

hNLCs

340.5

24

Mitochondrial function (MTT assay)

23

hNLCs

298.3

48

Mitochondrial function (MTT assay)

23

hNLCs

312.1

24

Cytotoxicity (trypan blue exclusion test)

23

hNLCs

220.8

48

Cytotoxicity (trypan blue exclusion test)

23

hNLCs

Not Determinedb

24

Apoptosis (nuclear staining with Hoechst 33258 dye)

23

hNLCs

Not Determinedb

48

Apoptosis (nuclear staining with Hoechst 33258 dye)

23

  1. aEC50 values were determined through non-linear regression (variable slope, four parameters) using GraphPad Prism 9, except where specified in the literature.
  2. bEC50 values are not provided due to insufficient data for robust curve fitting.